SCHEMBL4907654

SCHEMBL4907654

CCCCc1ccc(C(=O)C(OC)C(=O)c2ccc(C(C)(C)C)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.49
ESRRG P62508 3/20 0.47
RARB P10826 1/20 0.46
NR1H4 Q96RI1 2/20 0.45
HDAC3 O15379 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
ESRRB O95718 1/20 0.43
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
EPHX2 P34913 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL633584 0.85 TRPV1 (0.54) PLK1RARBTHRATHRBTRPV1
SCHEMBL4411275 0.78 MAPT (0.53) ESRRGRARBHDAC1MEN1NPC1
SCHEMBL547838 0.77 KCNH2 (0.60) PLK1ESRRGNPC1RAB9ALMNA
SCHEMBL20968926 0.77 ESRRG (0.51) PLK1ESRRGRARBNR1H4HDAC3
SCHEMBL20968925 0.77 ESRRG (0.51) PLK1ESRRGRARBNR1H4HDAC3
SCHEMBL7302615 0.75 NR1H4 (0.76) PLK1ESRRGNR1H4HDAC3HDAC8
SCHEMBL10708524 0.74 THRB (0.52) PLK1ESRRGRARBNR1H4THRA
SCHEMBL545445 0.73 CYP4F2 (0.47) TRPV1
SCHEMBL21448657 0.73 TSHR (0.46) PLK1ESRRGRARBNR1H4HDAC3
SCHEMBL8902478 0.73 RARB (0.59) PLK1RARBTHRATHRBTRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080026020-A1 Cosmetic composition combining a C-glycoside derivative and an associative polymer L'OREAL (FR) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080026020-A1 Cosmetic composition combining a C-glycoside derivative and an associative polymer UGCG, GLA, GANC PLK1 2378/4885ESRRG 3443/4885RARB 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.